|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM184452120 |
| 003 |
DE-627 |
| 005 |
20231223170649.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231223s2009 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2008.09.013
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0615.xml
|
| 035 |
|
|
|a (DE-627)NLM184452120
|
| 035 |
|
|
|a (NLM)19004669
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Roesler, Joachim
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Carriers of X-linked chronic granulomatous disease at risk
|
| 264 |
|
1 |
|c 2009
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 27.01.2009
|
| 500 |
|
|
|a Date Revised 19.11.2015
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a CommentOn: Clin Immunol. 2008 Nov;129(2):372-80. - PMID 18774749
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a Comment
|
| 650 |
|
4 |
|a Letter
|
| 650 |
|
7 |
|a Anti-Infective Agents
|2 NLM
|
| 650 |
|
7 |
|a Antifungal Agents
|2 NLM
|
| 650 |
|
7 |
|a Antiprotozoal Agents
|2 NLM
|
| 650 |
|
7 |
|a Itraconazole
|2 NLM
|
| 650 |
|
7 |
|a 304NUG5GF4
|2 NLM
|
| 650 |
|
7 |
|a Trimethoprim, Sulfamethoxazole Drug Combination
|2 NLM
|
| 650 |
|
7 |
|a 8064-90-2
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 130(2009), 2 vom: 15. Feb., Seite 233; author reply 234
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:130
|g year:2009
|g number:2
|g day:15
|g month:02
|g pages:233; author reply 234
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.09.013
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 130
|j 2009
|e 2
|b 15
|c 02
|h 233; author reply 234
|